• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结构简单的二价锇(II)多吡啶配合物作为近红外光动力治疗的光敏剂。

Structurally Simple Osmium(II) Polypyridyl Complexes as Photosensitizers for Photodynamic Therapy in the Near Infrared.

机构信息

Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, 75005, Paris, France.

National Institute of Applied Sciences and Technology, Carthage University, EcoChimie Laboratory, Tunis, Tunisia.

出版信息

Angew Chem Int Ed Engl. 2023 May 8;62(20):e202218347. doi: 10.1002/anie.202218347. Epub 2023 Apr 12.

DOI:10.1002/anie.202218347
PMID:36917074
Abstract

Five osmium(II) polypyridyl complexes of the general formula [Os(4,7-diphenyl-1,10-phenanthroline) L] were synthesized as photosensitizers for photodynamic therapy by varying the nature of the ligand L. Thanks to the pronounced π-extended structure of the ligands and the heavy atom effect provided by the osmium center, these complexes exhibit a high absorption in the near-infrared (NIR) region (up to 740 nm), unlike related ruthenium complexes. This led to a promising phototoxicity in vitro against cancer cells cultured as 2D cell layers but also in multicellular tumor spheroids upon irradiation at 740 nm. The complex [Os(4,7-diphenyl-1,10-phenanthroline) (2,2'-bipyridine)] was found to be the most efficient against various cancer cell lines, with high phototoxicity indexes. Experiments on CT26 tumor-bearing BALB/c mice also indicate that the Os complexes could significantly reduce tumor growth following 740 nm laser irradiation. The high phototoxicity in the biological window of this structurally simple complex makes it a promising photosensitizer for cancer treatment.

摘要

五种[Os(4,7-二苯基-1,10-菲咯啉)L]的钌(II)多吡啶配合物被合成出来作为光动力治疗的光敏剂,通过改变配体 L 的性质。由于配体具有明显的π扩展结构和中心的钌原子的重原子效应,这些配合物在近红外(NIR)区域(高达 740nm)具有高吸收,这与相关的钌配合物不同。这导致了在体外培养的二维细胞层和在 740nm 照射下的多细胞肿瘤球体中对癌细胞具有有前途的光毒性。发现[Os(4,7-二苯基-1,10-菲咯啉)(2,2'-联吡啶)]对各种癌细胞系最有效,具有高的光毒性指数。在 CT26 荷瘤 BALB/c 小鼠上的实验也表明,Os 配合物在 740nm 激光照射后可以显著减少肿瘤生长。这种结构简单的配合物在生物窗口中具有高的光毒性,使其成为治疗癌症的有前途的光敏剂。

相似文献

1
Structurally Simple Osmium(II) Polypyridyl Complexes as Photosensitizers for Photodynamic Therapy in the Near Infrared.结构简单的二价锇(II)多吡啶配合物作为近红外光动力治疗的光敏剂。
Angew Chem Int Ed Engl. 2023 May 8;62(20):e202218347. doi: 10.1002/anie.202218347. Epub 2023 Apr 12.
2
Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy.Ru(II) 金属卟啉配合物作为单光子和双光子光动力治疗光敏剂的应用的关键综述。
Acc Chem Res. 2017 Nov 21;50(11):2727-2736. doi: 10.1021/acs.accounts.7b00180. Epub 2017 Oct 23.
3
π-Expansive Heteroleptic Ruthenium(II) Complexes as Reverse Saturable Absorbers and Photosensitizers for Photodynamic Therapy.作为光动力疗法的反向饱和吸收剂和光敏剂的π-扩展异核钌(II)配合物
Inorg Chem. 2017 Mar 20;56(6):3245-3259. doi: 10.1021/acs.inorgchem.6b02624. Epub 2017 Mar 6.
4
Increased Lipophilicity of Halogenated Ruthenium(II) Polypyridyl Complexes Leads to Decreased Phototoxicity in vitro when Used as Photosensitizers for Photodynamic Therapy.卤化钌(II)多吡啶配合物亲脂性增加,用作光动力疗法的光敏剂时,体外光毒性降低。
Chembiochem. 2020 Oct 15;21(20):2966-2973. doi: 10.1002/cbic.202000289. Epub 2020 Jul 7.
5
Polymeric Encapsulation of a Ruthenium Polypyridine Complex for Tumor Targeted One- and Two-Photon Photodynamic Therapy.聚合物包裹钌多吡啶配合物用于肿瘤靶向的单光子和双光子光动力治疗。
ACS Appl Mater Interfaces. 2020 Dec 9;12(49):54433-54444. doi: 10.1021/acsami.0c16119. Epub 2020 Nov 25.
6
Design of a Tris-Heteroleptic Ru(II) Complex with Red-Light Excitation and Remarkably Improved Photobiological Activity.设计一种具有红光激发和显著提高的光生物活性的三齿杂配钌(II)配合物。
Inorg Chem. 2020 Aug 3;59(15):11193-11204. doi: 10.1021/acs.inorgchem.0c01860. Epub 2020 Jul 23.
7
Novel Osmium-based Coordination Complexes as Photosensitizers for Panchromatic Photodynamic Therapy.新型基于锇的配位配合物作为全光谱光动力治疗的光敏剂。
Photochem Photobiol. 2017 Oct;93(5):1248-1258. doi: 10.1111/php.12767. Epub 2017 Jun 13.
8
Os(II) Oligothienyl Complexes as a Hypoxia-Active Photosensitizer Class for Photodynamic Therapy.Os(II) 低聚噻吩基配合物作为一种缺氧激活型光动力治疗光敏剂。
Inorg Chem. 2020 Nov 16;59(22):16341-16360. doi: 10.1021/acs.inorgchem.0c02137. Epub 2020 Oct 30.
9
Future potential of osmium complexes as anticancer drug candidates, photosensitizers and organelle-targeted probes.锇配合物作为抗癌药物候选物、光动力治疗试剂和靶向细胞器探针的未来潜力。
Dalton Trans. 2018 Oct 30;47(42):14841-14854. doi: 10.1039/c8dt03432j.
10
Panchromatic Osmium Complexes for Photodynamic Therapy: Solutions to Existing Problems and New Questions.多色锇配合物用于光动力疗法:解决现有问题和提出新问题。
Photochem Photobiol. 2017 Oct;93(5):1326-1328. doi: 10.1111/php.12796. Epub 2017 Aug 7.

引用本文的文献

1
Efficient Red Light-Driven Singlet Oxygen Photocatalysis with an Osmium-Based Coulombic Dyad.基于锇的库仑二元体实现高效红光驱动单线态氧光催化
Angew Chem Int Ed Engl. 2025 Aug 25;64(35):e202502840. doi: 10.1002/anie.202502840. Epub 2025 Jul 15.
2
Excited-State and Pt(IV) Diamine Anticancer Complexes.激发态与铂(IV)二胺抗癌配合物
Inorg Chem. 2025 May 28. doi: 10.1021/acs.inorgchem.5c01882.
3
Protoporphyrin IX-Derived Ruthenium(II) Complexes for Photodynamic Therapy in Gastric Cancer Cells.用于胃癌细胞光动力治疗的原卟啉IX衍生钌(II)配合物
Inorg Chem. 2025 May 19;64(19):9684-9702. doi: 10.1021/acs.inorgchem.5c00896. Epub 2025 May 2.
4
Endogenous Near-Infrared Chemiluminescence: Imaging-Guided Non-Invasive Thrombolysis and Anti-Inflammation Based on a Heteronuclear Transition Metal Complex.内源性近红外化学发光:基于异核过渡金属配合物的成像引导无创溶栓与抗炎作用
Adv Sci (Weinh). 2025 May;12(19):e2501257. doi: 10.1002/advs.202501257. Epub 2025 Mar 26.
5
Improved Orthogonality in Naphthalimide/Cyanine Dyad Boosts Superoxide Generation: a Tumor-Targeted Type-I Photosensitizer for Photodynamic Therapy of Tumor by Inducing Ferroptosis.萘酰亚胺/花菁二元体系中改善的正交性促进超氧阴离子生成:一种通过诱导铁死亡实现肿瘤靶向I型光动力治疗肿瘤的光敏剂
Adv Sci (Weinh). 2025 May;12(17):e2417179. doi: 10.1002/advs.202417179. Epub 2025 Mar 6.
6
A rhodamine-coordinated iridium complex to overcome cisplatin-resistant cancer via regulating mitochondrial function triggered apoptosis and ferroptosis.一种罗丹明配位的铱配合物通过调节线粒体功能触发细胞凋亡和铁死亡来克服顺铂耐药性癌症。
Redox Biol. 2025 Apr;81:103536. doi: 10.1016/j.redox.2025.103536. Epub 2025 Feb 10.
7
Platinum Group Metals against Parasites: State of the Art and Future Perspectives.铂族金属与寄生虫:现状与未来展望。
Med Chem. 2025;21(1):2-10. doi: 10.2174/0115734064324855240806052735.
8
Two in one: merging photoactivated chemotherapy and photodynamic therapy to fight cancer.合二为一:融合光活化化疗与光动力疗法对抗癌症。
Chem Sci. 2024 Oct 15;15(43):17760-80. doi: 10.1039/d4sc04608k.
9
Leveraging the Photofunctions of Transition Metal Complexes for the Design of Innovative Phototherapeutics.利用过渡金属配合物的光功能设计创新的光疗方法。
Small Methods. 2024 Nov;8(11):e2400563. doi: 10.1002/smtd.202400563. Epub 2024 Sep 25.
10
Photodynamic therapy for cancer: mechanisms, photosensitizers, nanocarriers, and clinical studies.癌症的光动力疗法:作用机制、光敏剂、纳米载体及临床研究。
MedComm (2020). 2024 Jun 22;5(7):e603. doi: 10.1002/mco2.603. eCollection 2024 Jul.